Concepedia

K. P. Johnson

KP

Statistics

Publications

8

Citations

2.1K

H-Index

8

Active since

1984

Affiliations

University of Maryland, Baltimore(Current)

K. P. Johnson is an author at University of Maryland, Baltimore specializing in multiple sclerosis, medicine, and neurology.

Top concepts

MedicineMultiple SclerosisNeurologyNeuroimmunologyImmunologyAutoimmunityAutoimmune DiseaseNeuropathologyImmunodeficiencyStroke

Publications per year

1984–1998

8

Publications

8

EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERON

H. S. Panitch, AndreaS. Haley, RobertL. Hirsch et al. · The Lancet · 1987 · 1.1K citations

Autoimmune Disease, Neurological Disorder, Medicine +8

Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability

K. P. Johnson, Benjamin Brooks, J. A. Cohen et al. · Neurology · 1998 · 511 citations

Glatiramer Acetate Treatment, Rheumatology, Clinical Therapeutic +13

Systemic alpha‐interferon therapy of multiple sclerosis

Robert L. Knobler, H. S. Panitch, S. L. Braheny et al. · Neurology · 1984 · 129 citations

Systemic Recombinant Human Interferon-β Treatment of Relapsing–Remitting Multiple Sclerosis: Pilot Study Analysis and Six-Year Follow-Up

Robert L. Knobler, Jeffrey I. Greenstein, K. P. Johnson et al. · Journal of Interferon Research · 1993 · 109 citations

Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients

C. T. Bever, Paul A. Anderson, James Leslie et al. · Neurology · 1996 · 76 citations

Crossover Trial, Neurological Disorder, Diaminopyridine Improves +16

1–5 of 8